Pantoprazol Accord (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Accord, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Accord belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates mucosal healing and reduces further erosion. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with the disorder.

Pantoprazol Accord may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild cramping. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: asymptomatic increase in ALT/AST. - Bone fracture risk: especially with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy with Pantoprazol Accord, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Evaluate hepatic status: monitor if liver disease is present. - Review long‑term use: prolonged therapy may increase fracture risk. - Monitor electrolytes: especially magnesium during extended treatment. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Accord can affect the pharmacokinetics of several co‑administered medicines. Awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Digoxin: possible rise in serum levels. - Methotrexate (high dose): reduced clearance may raise toxicity risk.